Search This Blog

Saturday, July 16, 2016

Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan

Exclusive Agreement Includes Nine Biosimilars



Amgen - Investors - RSS Content

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.